11-533308-CG-CGG
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PVS1_ModerateBS2
The NM_176795.5(HRAS):c.500dupC(p.Pro169fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000631 in 1,600,628 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000067 ( 0 hom. )
Consequence
HRAS
NM_176795.5 frameshift
NM_176795.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.184
Genes affected
HRAS (HGNC:5173): (HRas proto-oncogene, GTPase) This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene. [provided by RefSeq, Jul 2008]
LRRC56 (HGNC:25430): (leucine rich repeat containing 56) Predicted to be involved in cell projection organization. Predicted to be located in cilium. Implicated in primary ciliary dyskinesia 39. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0253 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
BS2
High AC in GnomAdExome4 at 97 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HRAS | NM_176795.5 | c.500dupC | p.Pro169fs | frameshift_variant | 5/6 | ENST00000417302.7 | NP_789765.1 | |
HRAS | NM_005343.4 | c.450+144dupC | intron_variant | ENST00000311189.8 | NP_005334.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HRAS | ENST00000417302.7 | c.500dupC | p.Pro169fs | frameshift_variant | 5/6 | 5 | NM_176795.5 | ENSP00000388246.1 | ||
HRAS | ENST00000311189.8 | c.450+144dupC | intron_variant | 1 | NM_005343.4 | ENSP00000309845.7 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151878Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
4
AN:
151878
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000304 AC: 7AN: 230592Hom.: 0 AF XY: 0.0000394 AC XY: 5AN XY: 127044
GnomAD3 exomes
AF:
AC:
7
AN:
230592
Hom.:
AF XY:
AC XY:
5
AN XY:
127044
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000670 AC: 97AN: 1448750Hom.: 0 Cov.: 34 AF XY: 0.0000610 AC XY: 44AN XY: 721066
GnomAD4 exome
AF:
AC:
97
AN:
1448750
Hom.:
Cov.:
34
AF XY:
AC XY:
44
AN XY:
721066
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151878Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74198
GnomAD4 genome
AF:
AC:
4
AN:
151878
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74198
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Congenital fibrosis of extraocular muscles Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Feb 26, 2024 | The heterozygous c.450+144dup variant in HRAS was identified in 1 individual with congenital fibrosis of extraocular muscles (CFEOM) and cystic hygroma via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Engle lab (https://kirbyneuro.org/EngleLab/). While this gene has a definitive gene-disease association with Costello Syndrome, it is lacking sufficient evidence to establish a gene-disease relationship with CFEOM. We believe this is a possible novel gene candidate for CFEOM. Given the limited information about this gene-disease relationship, the significance of the c.450+144dup variant is uncertain. If you have any additional information about functional evidence or other individuals with this phenotype that also have variants in HRAS we encourage you to reach out to the Engle Lab (elizabeth.engle@childrens.harvard.edu). - |
Costello syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | May 03, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at